Lipid-Lowering and Anti-Inflammatory Benefits of Statin Therapy: More Than Meets the Plaque

Overview

Journal Circ Cardiovasc Imaging

Specialties Cardiology & Vascular Diseases
Radiology

Date 2017 Jul 7

PMID 28679526

Citations 12

Authors

Viviany R Taqueti

Paul M Ridker

Affiliations

Soon will be listed here.

Citing Articles

Macrophage polarization markers in subcutaneous, pericardial, and epicardial adipose tissue are altered in patients with coronary heart disease.

Papotti B, Opstad T, Akra S, Tonnessen T, Braathen B, Hansen C Front Cardiovasc Med. 2023; 10:1055069.

PMID: 36937936 PMC: 10017535. DOI: 10.3389/fcvm.2023.1055069.

Pre-Stroke Statin Use Is Associated with Mild Neurological Deficits at the Onset of Acute Ischemic Stroke.

Mori T, Yoshioka K, Miyazaki Y J Cardiovasc Dev Dis. 2022; 9(11).

PMID: 36421931 PMC: 9692373. DOI: 10.3390/jcdd9110396.

Frozen shoulder.

Millar N, Meakins A, Struyf F, Willmore E, Campbell A, Kirwan P Nat Rev Dis Primers. 2022; 8(1):59.

PMID: 36075904 DOI: 10.1038/s41572-022-00386-2.

The relationship between dyslipidemia and inflammation among adults in east coast China: A cross-sectional study.

Hong N, Lin Y, Ye Z, Yang C, Huang Y, Duan Q Front Immunol. 2022; 13:937201.

PMID: 36032093 PMC: 9403313. DOI: 10.3389/fimmu.2022.937201.

Cardioprotective Effect of Low Level of LDL Cholesterol on Perioperative Myocardial Injury in Off-Pump Coronary Artery Bypass Grafting.

Urbanowicz T, Olasinska-Wisniewska A, Michalak M, Gasecka A, Rodzki M, Perek B Medicina (Kaunas). 2021; 57(9).

PMID: 34577798 PMC: 8466423. DOI: 10.3390/medicina57090875.

References

Bohula E, Giugliano R, Cannon C, Zhou J, Murphy S, White J . Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT. Circulation. 2015; 132(13):1224-33. DOI: 10.1161/CIRCULATIONAHA.115.018381. View

Nissen S, Tuzcu E, Schoenhagen P, Brown B, Ganz P, Vogel R . Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA. 2004; 291(9):1071-80. DOI: 10.1001/jama.291.9.1071. View

Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H . Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation. 2004; 110(9):1061-8. DOI: 10.1161/01.CIR.0000140261.58966.A4. View

Taqueti V, Everett B, Murthy V, Gaber M, Foster C, Hainer J . Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation. 2014; 131(6):528-35. PMC: 4323995. DOI: 10.1161/CIRCULATIONAHA.114.009716. View

Park S, Kang S, Ahn J, Chang M, Yun S, Roh J . Effect of Statin Treatment on Modifying Plaque Composition: A Double-Blind, Randomized Study. J Am Coll Cardiol. 2016; 67(15):1772-1783. DOI: 10.1016/j.jacc.2016.02.014. View

Nissen S, Tuzcu E, Schoenhagen P, Crowe T, Sasiela W, Tsai J . Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med. 2005; 352(1):29-38. DOI: 10.1056/NEJMoa042000. View

Jensen L, Thayssen P, Pedersen K, Stender S, Haghfelt T . Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study. Circulation. 2004; 110(3):265-70. DOI: 10.1161/01.CIR.0000135215.75876.41. View

Ridker P . Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT). J Thromb Haemost. 2009; 7 Suppl 1:332-9. DOI: 10.1111/j.1538-7836.2009.03404.x. View

Stone N, Robinson J, Lichtenstein A, Merz C, Blum C, Eckel R . 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 129(25 Suppl 2):S1-45. DOI: 10.1161/01.cir.0000437738.63853.7a. View

10.

Nissen S, Nicholls S, Sipahi I, Libby P, Raichlen J, Ballantyne C . Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA. 2006; 295(13):1556-65. DOI: 10.1001/jama.295.13.jpc60002. View

11.

Kwon O, Kang S, Kang S, Lee P, Yun S, Ahn J . Relationship Between Serum Inflammatory Marker Levels and the Dynamic Changes in Coronary Plaque Characteristics After Statin Therapy. Circ Cardiovasc Imaging. 2017; 10(7). DOI: 10.1161/CIRCIMAGING.116.005934. View

12.

Ridker P . Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin. Eur Heart J. 2016; 37(22):1720-2. DOI: 10.1093/eurheartj/ehw024. View

13.

Ridker P, Cannon C, Morrow D, Rifai N, Rose L, McCabe C . C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005; 352(1):20-8. DOI: 10.1056/NEJMoa042378. View

14.

Nasu K, Tsuchikane E, Katoh O, Tanaka N, Kimura M, Ehara M . Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound. JACC Cardiovasc Interv. 2009; 2(7):689-96. DOI: 10.1016/j.jcin.2009.04.016. View

15.

Ridker P, Thuren T, Zalewski A, Libby P . Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). Am Heart J. 2011; 162(4):597-605. DOI: 10.1016/j.ahj.2011.06.012. View

16.

Taqueti V, Di Carli M, Jerosch-Herold M, Sukhova G, Murthy V, Folco E . Increased microvascularization and vessel permeability associate with active inflammation in human atheromata. Circ Cardiovasc Imaging. 2014; 7(6):920-9. PMC: 4237630. DOI: 10.1161/CIRCIMAGING.114.002113. View

17.

Nicholls S, Ballantyne C, Barter P, Chapman M, Erbel R, Libby P . Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med. 2011; 365(22):2078-87. DOI: 10.1056/NEJMoa1110874. View

18.

Stone G, Maehara A, Lansky A, De Bruyne B, Cristea E, Mintz G . A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011; 364(3):226-35. DOI: 10.1056/NEJMoa1002358. View

19.

Taqueti V, Shaw L, Cook N, Murthy V, Shah N, Foster C . Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease. Circulation. 2016; 135(6):566-577. PMC: 5459611. DOI: 10.1161/CIRCULATIONAHA.116.023266. View

20.

Ridker P . From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection. Circ Res. 2016; 118(1):145-56. PMC: 4793711. DOI: 10.1161/CIRCRESAHA.115.306656. View